rs41271747
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000521.4(HEXB):c.300-46T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.093 in 1,504,790 control chromosomes in the GnomAD database, including 7,705 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.070 ( 505 hom., cov: 33)
Exomes 𝑓: 0.096 ( 7200 hom. )
Consequence
HEXB
NM_000521.4 intron
NM_000521.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.258
Publications
4 publications found
Genes affected
HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
HEXB Gene-Disease associations (from GenCC):
- Sandhoff diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 5-74689282-T-A is Benign according to our data. Variant chr5-74689282-T-A is described in ClinVar as Benign. ClinVar VariationId is 256357.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HEXB | ENST00000261416.12 | c.300-46T>A | intron_variant | Intron 1 of 13 | 1 | NM_000521.4 | ENSP00000261416.7 | |||
| HEXB | ENST00000511181.5 | c.-376-46T>A | intron_variant | Intron 1 of 13 | 1 | ENSP00000426285.1 | ||||
| HEXB | ENST00000513079.5 | n.365-46T>A | intron_variant | Intron 1 of 5 | 2 | |||||
| HEXB | ENST00000515528.1 | n.355-46T>A | intron_variant | Intron 1 of 1 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0702 AC: 10684AN: 152182Hom.: 506 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
10684
AN:
152182
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0720 AC: 17981AN: 249768 AF XY: 0.0722 show subpopulations
GnomAD2 exomes
AF:
AC:
17981
AN:
249768
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0956 AC: 129276AN: 1352490Hom.: 7200 Cov.: 23 AF XY: 0.0934 AC XY: 63457AN XY: 679456 show subpopulations
GnomAD4 exome
AF:
AC:
129276
AN:
1352490
Hom.:
Cov.:
23
AF XY:
AC XY:
63457
AN XY:
679456
show subpopulations
African (AFR)
AF:
AC:
494
AN:
30994
American (AMR)
AF:
AC:
2054
AN:
44564
Ashkenazi Jewish (ASJ)
AF:
AC:
2316
AN:
25526
East Asian (EAS)
AF:
AC:
3
AN:
39194
South Asian (SAS)
AF:
AC:
1838
AN:
83792
European-Finnish (FIN)
AF:
AC:
5160
AN:
52460
Middle Eastern (MID)
AF:
AC:
320
AN:
5322
European-Non Finnish (NFE)
AF:
AC:
112037
AN:
1013838
Other (OTH)
AF:
AC:
5054
AN:
56800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
5764
11529
17293
23058
28822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3824
7648
11472
15296
19120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0702 AC: 10689AN: 152300Hom.: 505 Cov.: 33 AF XY: 0.0682 AC XY: 5079AN XY: 74470 show subpopulations
GnomAD4 genome
AF:
AC:
10689
AN:
152300
Hom.:
Cov.:
33
AF XY:
AC XY:
5079
AN XY:
74470
show subpopulations
African (AFR)
AF:
AC:
779
AN:
41576
American (AMR)
AF:
AC:
909
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
290
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
119
AN:
4832
European-Finnish (FIN)
AF:
AC:
1096
AN:
10604
Middle Eastern (MID)
AF:
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7237
AN:
68026
Other (OTH)
AF:
AC:
162
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
498
996
1495
1993
2491
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
44
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.